Check-Cap (NASDAQ:CHEK) Coverage Initiated at StockNews.com

Equities research analysts at StockNews.com initiated coverage on shares of Check-Cap (NASDAQ:CHEK) in a report issued on Tuesday. The firm set a “sell” rating on the medical research company’s stock.

Check-Cap Trading Down 4.5 %

Shares of Check-Cap stock opened at $0.85 on Tuesday. The company has a 50-day moving average of $0.92 and a two-hundred day moving average of $1.10. Check-Cap has a 12-month low of $0.56 and a 12-month high of $3.45. The stock has a market cap of $4.97 million, a PE ratio of -0.28 and a beta of 0.19.

About Check-Cap

Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule for detection of suspected polyps; C-Scan Track, a disposable system attached to the patient's back through biocompatible adhesive skin patches; and C-Scan View software, a client/server-based application that enables procedure data download from the C-Scan Track, data analysis, and report generation.